.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia has demonstrated strong performance in the Illinois market, particularly in the Topical category, where it consistently held the number one spot from September to December 2025. This category showed a remarkable increase in sales, peaking in December. In the Capsules category, Avexia maintained a steady second-place ranking, with a noticeable sales increase from September to November before a slight dip in December. However, in the Concentrates category, Avexia's position weakened, dropping from 21st to 26th place, indicating a declining trend in sales over the four months.
In Maryland, Avexia's performance was mixed across different categories. The brand saw a strong presence in the Topical category, climbing to the top position by December. Meanwhile, in the Capsules category, Avexia managed to regain its second-place ranking after a brief drop to third in October. The Concentrates category told a different story, as Avexia fell out of the top 20 by December, indicating a significant decline in sales. In New Jersey, Avexia's presence in the Tincture & Sublingual category was noteworthy in September, although it did not rank in the top 30 in the subsequent months, which could be a point of concern for the brand's market strategy.
Competitive Landscape
In the Illinois topical cannabis market, Avexia has consistently maintained its top position from September to December 2025, showcasing its dominance in this category. Despite a slight dip in sales in October, Avexia's sales rebounded significantly by December, reinforcing its strong market presence. In contrast, Doctor Solomon's, which holds the second rank, has shown relatively stable sales figures but remains significantly behind Avexia in terms of sales volume. Meanwhile, Pheotera Grove has seen some fluctuations in its rank, moving between fourth and fifth place, with a notable increase in sales in December. These dynamics indicate that while Avexia continues to lead the market, competitors like Doctor Solomon's and Pheotera Grove are striving to close the gap, highlighting the competitive nature of the Illinois topical cannabis market.
Notable Products
In December 2025, Avexia's top-performing product was the CBD/THC 1:1 Harmony Pain Relief Balm, maintaining its first-place position with sales reaching 9,033 units. The CBN/CBD/THC 1:1:1 Comfort Tablets rose to second place, surpassing previous months' consistent third position, indicating a notable increase in consumer preference. The CBD/THC 1:1 Harmony Micro-Dosed Tablets secured the third spot, reflecting a steady upward trend in sales over the past months. CBG/THC 1:1 Ascend Tablets moved up to fourth place, continuing its gradual climb in the rankings. Meanwhile, the CBD/THC 4:1 Relief Tablets dropped to fifth place, despite stable sales figures, suggesting a shift in category demand.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
